Great West Life Assurance CO Celldex Therapeutics, Inc. Transaction History
Great West Life Assurance CO
- $53.1 Billion
- Q2 2024
A detailed history of Great West Life Assurance CO transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 13,617 shares of CLDX stock, worth $376,237. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,617
Previous 4,570
197.96%
Holding current value
$376,237
Previous $192,000
163.02%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CLDX
# of Institutions
196Shares Held
63.8MCall Options Held
212KPut Options Held
176K-
Wellington Management Group LLP Boston, MA8.08MShares$223 Million0.05% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$130 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$103 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.39MShares$93.6 Million9.76% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$91.9 Million2.17% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.29B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...